Quintiles Moves Fast In China With Dalian Center and Shanghai Lab As Local Studies Explode
This article was originally published in PharmAsia News
Executive Summary
After launching its local entity Kun Tuo in China, CRO Quintiles accelerated its pace in China with the opening of a center of excellence in Dalian and a partnership with Shanghai Clinical Research Center.
You may also be interested in...
People In The News: Tracking The Latest Industry Personnel Moves
New top leadership at Kolltan Pharmaceuticals, Array BioPharma and Quintiles; Ipsen names its North American leadership team. More personnel announcements in this month’s column
Quintiles-Invested Samsung Biologics Proceeds On Schedule
SEOUL - South Korea's largest conglomerate Samsung Group announced April 22 the CEO and the company name of a joint venture with Quintiles Transnational Corp. making inroads into the biosimilar and biopharmaceutical business
Change Of Guard At Quintiles India As Company Continues Aggressive Asia Efforts With Samsung Deal
MUMBAI - Quintiles Transnational Corp.'s India CEO Ferzaan Engineer will step down after serving the multinational contract research organization since its inception in India more than 13 years ago